Insiders CytomX Therapeutics, Inc.

Equities

CTMX

US23284F1057

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-26 EDT			5-day change	1st Jan Change
1.21 ^USD	0.00%		-6.20%	-21.94%

06-17	CytomX Therapeutics, Inc. Promotes Chris Ogden to Chief Financial Officer	CI
05-28	Piper Sandler Upgrades CytomX Therapeutics to Overweight From Neutral, Adjusts Price Target to $3.50 From $2.25	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CytomX Therapeutics, Inc. Promotes Chris Ogden to Chief Financial Officer	06-17	CI
CytomX Therapeutics, Inc. Appoints Dr. Zhen Su to Board of Directors	03-21	CI
Exelixis Appoints Amy Peterson as Chief Medical Officer	23-08-23	MT
CytomX Therapeutics, Inc. Appoints Yu-Waye Chu as Chief Medical Officer	23-07-18	CI
CytomX Therapeutics, Inc. Announces Executive Changes	22-09-23	CI
CytomX Therapeutics, Inc. Announces Departure of Carlos Campoy as Chief Financial Officer, Effective as of September 30, 2022	22-09-23	CI
CytomX Therapeutics, Inc. Announces Executive Terminations	22-07-13	CI
Aptose Biosciences Appoints Fletcher Payne as CFO	22-06-27	MT
Cytomx Therapeutics Announces Retirement of John A. Scarlett from Board of Directors and Chair of the Compensation Committee and A Member of the Audit Committee	22-04-14	CI
CytomX Therapeutics, Inc. Announces Retirement of Frederick W. Gluck from Board of Directors	22-03-23	CI
CytomX Therapeutics, Inc. Appoints Chris Ogden as Interim Principal Accounting Officer	22-02-14	CI
CytomX Therapeutics Promotes Amy Peterson to President, Chief Operating Officer	22-02-07	MT
Cytomx Therapeutics, Inc. Announces Promotion of Amy C. Peterson, M.D. to President and Chief Operating Officer	22-02-07	CI
Cytomx Therapeutics, Inc. Appoints Alan Ashworth to Board of Directors	21-10-04	CI
Insider Trends: Insider Prolongs 90-Day Selling Trend at CytomX Therapeutics	21-06-21	MT
CytomX Therapeutics, Inc. Appoints Dr. Mani Mohindru to Board of Directors	20-12-22	CI
CytomX Therapeutics, Inc. Announces Planned Retirement of W. Michael Kavanaugh, Chief Scientific Officer, Head of Research and Non-Clinical Development on December 1, 2020	20-10-06	CI
CytomX Therapeutics, Inc. Appoints Halley E. Gilbert as Board of Directors	20-04-28	CI
CytomX Therapeutics, Inc. Appoints Carlos Campoy as Senior Vice President and Chief Financial Officer	20-03-23	CI
CytomX Therapeutics, Inc. Appoints Alison L. Hannah as Senior Vice President and Chief Medical Officer	20-02-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders CytomX Therapeutics, Inc.

Equities

CTMX

US23284F1057

Insiders

Filters